PL333847A1 - Crystalline forms of lansoprozole and method of obtaining lansoprazole in pharmacologically advanthageous crystalline form - Google Patents

Crystalline forms of lansoprozole and method of obtaining lansoprazole in pharmacologically advanthageous crystalline form

Info

Publication number
PL333847A1
PL333847A1 PL99333847A PL33384799A PL333847A1 PL 333847 A1 PL333847 A1 PL 333847A1 PL 99333847 A PL99333847 A PL 99333847A PL 33384799 A PL33384799 A PL 33384799A PL 333847 A1 PL333847 A1 PL 333847A1
Authority
PL
Poland
Prior art keywords
advanthageous
lansoprozole
lansoprazole
pharmacologically
obtaining
Prior art date
Application number
PL99333847A
Original Assignee
Inst Farmaceutyczny
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Farmaceutyczny filed Critical Inst Farmaceutyczny
Priority to PL99333847A priority Critical patent/PL333847A1/en
Priority to PCT/PL2000/000042 priority patent/WO2000078729A1/en
Publication of PL333847A1 publication Critical patent/PL333847A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
PL99333847A 1999-06-18 1999-06-18 Crystalline forms of lansoprozole and method of obtaining lansoprazole in pharmacologically advanthageous crystalline form PL333847A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL99333847A PL333847A1 (en) 1999-06-18 1999-06-18 Crystalline forms of lansoprozole and method of obtaining lansoprazole in pharmacologically advanthageous crystalline form
PCT/PL2000/000042 WO2000078729A1 (en) 1999-06-18 2000-06-15 Crystalline forms of lansoprazole

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL99333847A PL333847A1 (en) 1999-06-18 1999-06-18 Crystalline forms of lansoprozole and method of obtaining lansoprazole in pharmacologically advanthageous crystalline form

Publications (1)

Publication Number Publication Date
PL333847A1 true PL333847A1 (en) 2001-01-02

Family

ID=20074597

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99333847A PL333847A1 (en) 1999-06-18 1999-06-18 Crystalline forms of lansoprozole and method of obtaining lansoprazole in pharmacologically advanthageous crystalline form

Country Status (2)

Country Link
PL (1) PL333847A1 (en)
WO (1) WO2000078729A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100433735B1 (en) * 2001-06-27 2004-06-04 주식회사 씨트리 Preparation method of Lansoprazole having crystalline form I
DE10140492A1 (en) 2001-08-17 2003-08-14 Gruenenthal Gmbh Hydrates of optionally substituted 2- (2-pyridinyl) methylthio-1H-benzimidazoles and process for their preparation
CA2480352A1 (en) * 2002-03-27 2003-10-09 Teva Pharmaceutical Industries Ltd. Lansoprazole polymorphs and processes for preparation thereof
EP1681056A1 (en) * 2005-01-14 2006-07-19 Krka Tovarna Zdravil, D.D., Novo Mesto Process for preparing lansoprazole
KR100758600B1 (en) 2006-01-05 2007-09-13 주식회사 대웅제약 Process for preparing Crystalline Form A of Lansoprazole
ITMI20062481A1 (en) * 2006-12-22 2008-06-23 Recordati Chem Pharm PROCESS FOR PREPARING LANSOPRAZOLE SHAPES I MICROCRYSTALLINE
WO2012095859A1 (en) * 2011-01-12 2012-07-19 Hetero Research Foundation Polymorphs of dexlansoprazole salts
CN104829594A (en) * 2015-05-15 2015-08-12 苗怡文 Pharmaceutical lansoprazole compound for treating gastric ulcer
CN104958276A (en) * 2015-07-30 2015-10-07 青岛蓝盛洋医药生物科技有限责任公司 Pharmaceutical lansoprazole composition capsule for treating gastric ulcer
CN104997738A (en) * 2015-08-10 2015-10-28 青岛蓝盛洋医药生物科技有限责任公司 Medicine lansoprazole compound dry suspension treating gastropathy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK171989B1 (en) * 1987-08-04 1997-09-08 Takeda Chemical Industries Ltd Process for the preparation of 2- (2-pyridylmethylsulfinyl) benzimidazoles
TW385306B (en) * 1996-11-14 2000-03-21 Takeda Chemical Industries Ltd Method for producing crystals of benzimidazole derivatives

Also Published As

Publication number Publication date
WO2000078729A1 (en) 2000-12-28

Similar Documents

Publication Publication Date Title
HUP0200429A2 (en) Soluble receptor br43x2 and methods of using
GB2374100B (en) Underreamer and method of use
GB2349273B (en) Method of making photovoltaic device
HK1043613A1 (en) Microfibers and method of making
IL163864A0 (en) Improvement in apparatus for and methods of damagerepair
EP1183030A4 (en) Methods of making and using n-desmethylzopiclone
IL145904A0 (en) Functionally improved battery and method of making same
EP1198184A4 (en) Appliqu method and article
AP2001002305A0 (en) Improved prosthesis and method thereof
PL333847A1 (en) Crystalline forms of lansoprozole and method of obtaining lansoprazole in pharmacologically advanthageous crystalline form
PL352401A1 (en) Method of making nitroguanidine and nitroenamine derivatives
HUP0105398A3 (en) Counter rail and method of manufacturing thereof
HK1040421A1 (en) Ornament and method for preparation thereof
IL139386A0 (en) Dhea composition and method
HK1041227B (en) Sustained release implant and methods for preparation thereof
PL341752A1 (en) Method of obtaining aryloamino hydroxyantraquinones
GB2346869B (en) Improved carton and method of construction therefor
PL344620A1 (en) 1-alkoxymethyl-3-y-pyridinium salts and method of obtaining them _
PL332356A1 (en) Biopreparation and method of obtaining same
GB9924443D0 (en) Method of and means for forming structures
PL332676A1 (en) Method of obtaining benzidamine hydrochloride
PL343396A1 (en) Latticework and method of making same
PL333334A1 (en) Method of obtaining silylethenes
PL331683A1 (en) Method of obtaining sulphoxides
GB9917409D0 (en) Composition and method

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)